C0360390||anti-mycobacterial
C1254351||piperidinol derivatives
C0041296||Tuberculosis
C0041296||Tuberculosis
C0007465||cause of death
C0041296||Tuberculosis
C0013227||drug
C0040808||regimen
C1254351||anti-tubercular agents
C0206525||drug-resistant TB
C2603343||study
C1254351||piperidinol compound derivative
C0026926||Mycobacterium tuberculosis
C0004587||bacillus
C0279516||antibacterial
C1254351||piperidinol compound
C0024728||bis-Mannich base
C0243071||analogue
C0220825||evaluated
C0317761||M. smegmatis
C0018150||Gram-negative organisms
C0596402||Cytotoxicity
C2603343||studies
C0918012||selectivity index
C1254351||compounds
C0596988||mutants
C0317761||M. smegmatis
C1254351||piperidinol
C1254351||bis-Mannich base lead derivatives
C4277689||genetic modifications
C1254351||compounds
C1254351||piperidinol
C1254351||bis-Mannich base analogue
C0026912||mycobacteria
C0596402||cytotoxicity
C0918012||selectivity index
C0026912||mycobacteria
C0317761||M. smegmatis
C1254351||lead compounds
C0752046||single nucleotide polymorphisms
C1254351||piperidinol moiety
C1254351||compound class
C1254351||anti-tubercular agents